Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis-Reference-Cited by-同舟云学术

Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis

Published:2019-10-08 Issue:14 Volume:322 Page:1360
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Hochberg Marc C.¹,Guermazi Ali²³,Guehring Hans⁴,Aydemir Aida⁵,Wax Stephen⁵,Fleuranceau-Morel Patricia⁵,Reinstrup Bihlet Asger⁶,Byrjalsen Inger⁶,Ragnar Andersen Jeppe⁶,Eckstein Felix⁷⁸

Affiliation:

1. School of Medicine, University of Maryland, Baltimore

2. School of Medicine, Boston University, Boston, Massachusetts

3. Boston Imaging Core Lab LLC, Boston, Massachusetts

4. Merck KGaA, Darmstadt, Germany

5. EMD Serono Research and Development Institute Inc, Billerica, Massachusetts

6. Nordic Bioscience, Herlev, Denmark

7. Institute of Anatomy, Department of Imaging and Functional Musculoskeletal Research, Paracelsus Medical University Salzburg and Nuremberg, Salzburg, Austria

8. Chondrometrics GmbH, Ainring, Germany

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2752470/jama_hochberg_2019_oi_190107.pdf

Reference33 articles.

1. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.;Cross;Ann Rheum Dis,2014

2. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study.;Nüesch;BMJ,2011

3. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future.;Karsdal;Osteoarthritis Cartilage,2016

4. OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.;Hunter;Osteoarthritis Cartilage,2015